http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006008539-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f6e33603375c486b0ab3505830af9e8 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 |
| filingDate | 2004-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c70fc077899c7f970c60b232d179916a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90a64a17114769cdea2c085bcf925d15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_995aaabb55bb5861c659df3d14dc57d0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb79a821a67cc99719e47d54d5647ca7 |
| publicationDate | 2006-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2006008539-A |
| titleOfInvention | Pharmaceutical composition containing right sugar glucose lipid A analog |
| abstract | Disclosed is a compound having an excellent inhibitory effect on macrophage activity and useful as an anti-inflammatory agent, an anti-autoimmune disease agent, an immunosuppressive agent, a prognosis improving agent after coronary artery bypass surgery, or an anti-septic agent. The following general formula [Q is an oxygen atom, an alkylene group, a group -O-Alk- or a group -O-Alk-O-, R 1 , R 2 and R 4 are the same or different, and are a hydrogen atom, a replaceable alkyl group, a substituted An alkenyl group, a substituted alkynyl group, a substituted alkanoyl group, a substituted alkenoyl group or a substituted alkynyl group, R 3 is a substituted alkanoyl group, a substituted alkenoyl group or a substituted alkynyl group, R 5 is a hydrogen atom, A halogen atom, a hydroxyl group, a substituted alkoxy group, a substituted alkenyloxy group or a substituted alkynyloxy group; And a pharmacologically acceptable salt thereof as an active ingredient. [Selection figure] None |
| priorityDate | 2004-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 292.